Abiopharma

PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update

Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Cybin - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

10 Barrel Pub Beer Taps Big Buck Hunter for Epic Cheap Fun Hunting SZN – Limited Edition Cans, Dive Bar Prizes, and $10,000 Arcade Giveaway Ignite Pacific Northwest

Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes